9th Biosimilars Congregation 2016

Greeting From Virtue Insight,
I am happy to invite you and your colleagues to be a sponsor/ delegate for our upcoming”9th Biosimilars Congregation” The conference will be held on 22nd September 2016, The Lalit Hotel, Mumbai, India

CONFERENCE INTRODUCTION:-

Virtue Insight invites you to the 9th Biosimilars Congregation 2016 during 22nd September 2016 Mumbai - India. This 9th Biosimilars Congregation 2016 brings together scientists, researchers and CROs from around the world. Biologics are a highly effective class of medicines that are based on naturally occurring proteins and produced using living cells. Current concepts of drugs and biologics, Unique considerations for biologics, Early clinical development essentials, Cancer therapeutics, Comparability for Biologics, Biosimilar approvals are the points of discussion in this session.

 

9th Biosimilars Congregation 2016 conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Hence, this global event will look at the multiple facets of biosimilars, ranging from the evolving regulatory landscapes, biosimilar guidelines to the legal and economic aspects and current challenges in biosimilar development. This biosimilar conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, biosimilar products to the market place. By attending this biologics conference you will gain a comprehensive outlook on the key issues surrounding biosimilars. This event will provide an important platform for biosimilars stakeholders to discuss and share best practices in expediting development in Biosimilars 2016 and onwards.
KEY SPEAKERS:-
• DHILEEP KRISHNAMURTHY, Vice President & Head Global R&D API, Piramal Life Sciences
• BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila
• ARUN BHATT, Consultant - Clinical Research & Development
• PRITI THAKOR, Associate Director Medical Affairs, Merck
• INDRANIL BHATTACHARYA, Associate Director Medical Affairs, Eli Lilly
• ANINDITA DAS, Associate Director, Dr. Reddy's Laboratories
• MANISH VERMA, Director Medical Affairs, Sanofi
• DEBOLINA PARTAP, Associate Vice President and Head Legal, Wockhardt
• PARIKSHIT CHAUDHARI, Medical Affairs Manager, Nestle
• HANMANT BARKATE, VP & Head- Medical Services, Intas Pharmaceuticals
• AMARDEEP UDESHI, Head - Strategy and Market Assessment, Cipla Biologicals
• CHANDRA SEKHAR, Vice President Quality, Reliance Life Sciences
• SAMBIT PATNAIK, CEO & Medical Director, Clintech India
• KAVYA KADAM, Head- Global Clinical Operation, Cipla
• SUNIT MAITY, AVP - Product Development, Theramyt Novobiologics
• ANAY SHUKLA, Associate, Nishith Desai Associate
Plus many more….
KEY THEMES DISCUSED:-
1. Global biopharma policy & market trends
2. The future of biosimilars in India
3. The evolving biosimilar sector: Trends and Implications
4. Complex biological models in biosimilar development
5. Viable extrapolation strategies for biosimilars with special emphasis on TNF antagonists
6. Effectively communicate the value of biosimilar products to raise confidence in the class
7. Improving characterization of biosimilars with technology
8. Create a robust patient services and reimbursement support program for biosimilar products
9. The future of the biosimilar industry - mapping the evolution and development of the biosimilar sector
10. Forecasting the financial growth of biosimilars in the global healthcare marketplace
11. Planning of a biosimilar development project - what to consider from the very beginning
12. Clinical development strategies for biosimilars
13. Gaining Better Market Access: Is Commercial CMO Acceptable for the Biosimilars Market?
14. Regulatory Updates and Development
15. Be part of a major networking opportunity

WHO WILL YOU MEET:-

CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

1. Biopharmaceuticals/ Biotherapeutics
2. Follow on Biologics/Follow on Proteins
3. Biologics/Biotechnology/ Biogenerics
4. Legal Affairs
5. Intellectual Property
6. Health Economics
7. Pricing and Reimbursement
8. Clinical Immunology
9. Principal Scientist
10. Chief Scientific Officer
11. Process Control and Analytical Technologies
12. Analytical Characterisation
13. Regulatory Compliance
14. Pharmacovigilance
15. Drug Safety & Risk Management
16. Quality Affairs/ Quality Control
17. New Product Development
18. Process Science
19. Portfolio Management
20. Research & Development
21. Business Development
22. Business Operations
23. Scientific Affairs
24. Commercial Affairs
CONFERENCE BOOKING DETAILS:-
• Early Bird Discounted Price - 1 Delegate Pass (INR 6,000 + Tax (15%) per delegate) - Book and Pay before 09th August 2016 to avail the early bird discounted price. You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – [email protected]

• Standard Price (10th August 2016) - 1 or 2 Delegates (INR 7,000 + Tax (15%) per delegate) - You can simply email or call and book your conference delegate seats on TEL: + 91 44 64536444. Email – [email protected]

• Group Discounts - 3 or 4 Delegates - (INR 6,500 + Tax (15%) per delegate)

• Group Discounts - 5 and above Delegates - (INR 5,500 + Tax (15%) per delegate)

• Spot Registration on the day of the conference - 1 Day Conference - (INR 8,000 + Tax (15%) per delegate)

• Conference Sponsor & Exhibition Stall - Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to –TEL: + 91 44 64536444. Email - [email protected]